These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9597319)

  • 21. Methods for the assessment of skin atrophogenicity of topical corticosteroids.
    Marks R
    Dermatologica; 1976; 152 Suppl 1():117-26. PubMed ID: 133834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect on adrenal axis function of topically applied betamethasone valerate ointment 0.1%.
    Fischer GO
    Australas J Dermatol; 1983 Apr; 24(1):26-32. PubMed ID: 6312951
    [No Abstract]   [Full Text] [Related]  

  • 23. Microdialysis assessment of percutaneous penetration of ketoprofen after transdermal administration to hairless rats and domestic pigs.
    Shinkai N; Korenaga K; Okumura Y; Mizu H; Yamauchi H
    Eur J Pharm Biopharm; 2011 Aug; 78(3):415-21. PubMed ID: 21397690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate.
    Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö
    J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 1. Dermal atrophy.
    Young JM; Yoxall BE; Wagner BM
    Br J Dermatol; 1978 Dec; 99(6):655-63. PubMed ID: 737128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The technique of intracerebral microdialysis.
    Khan SH; Shuaib A
    Methods; 2001 Jan; 23(1):3-9. PubMed ID: 11162145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.
    Leal LB; Cordery SF; Delgado-Charro MB; Bunge AL; Guy RH
    Pharm Res; 2017 Apr; 34(4):730-737. PubMed ID: 28097506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of betamethasone 17-valerate from extemporaneous dilutions of a proprietary topical cream.
    Magnus AD; Haigh JM; Kanfer I
    Dermatologica; 1981; 163(4):331-7. PubMed ID: 7308554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of systemic and topical effects of topical steroid application through the comparison of two application schedules.
    Fukaya Y; Masutani M; Koyama Y; Takahashi H; Ueda H
    J Dermatol; 1990 Jan; 17(1):28-33. PubMed ID: 2329214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of ofloxacin penetration into the skin after a single oral dose assessed by cutaneous microdialysis.
    Bielecka-Grzela S; Klimowicz A
    Pol J Pharmacol; 2003; 55(4):613-8. PubMed ID: 14581720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of lipocortin 1 by topical steroid in rat skin.
    Ahluwalia A; Mohamed RW; Flower RJ
    Biochem Pharmacol; 1994 Oct; 48(8):1647-54. PubMed ID: 7980630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological evaluation of a new topical preparation containing dextran sulphate and betamethasone 17-valerate.
    Passarella E; Milanino R
    Arzneimittelforschung; 1980; 30(4):647-51. PubMed ID: 6156688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids.
    Schlupp P; Blaschke T; Kramer KD; Höltje HD; Mehnert W; Schäfer-Korting M
    Skin Pharmacol Physiol; 2011; 24(4):199-209. PubMed ID: 21346400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoencapsulation of betamethasone valerate using high pressure homogenization-solvent evaporation technique: optimization of formulation and process parameters for efficient dermal targeting.
    Md S; Kuldeep Singh JKA; Waqas M; Pandey M; Choudhury H; Habib H; Hussain F; Hussain Z
    Drug Dev Ind Pharm; 2019 Feb; 45(2):323-332. PubMed ID: 30404554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles.
    Zhang J; Smith E
    J Pharm Sci; 2011 Mar; 100(3):896-903. PubMed ID: 20839362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biophysical elucidation of the mechanism of enhanced drug release and topical delivery from polymeric film-forming systems.
    Garvie-Cook H; Frederiksen K; Petersson K; Guy RH; Gordeev SN
    J Control Release; 2015 Aug; 212():103-12. PubMed ID: 26087467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dynamic determination of sinomenine in skin by microdialysis].
    Ling JJ; Xie B; Wang Y; Zhou LL
    Zhong Yao Cai; 2008 Jul; 31(7):1062-5. PubMed ID: 18973024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of the base on the results of clinical trials with topical corticosteroids.
    Vollum DI; Sparkes CG
    Dermatologica; 1979; 158(4):293-8. PubMed ID: 372027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous microdialysis for the measurement in vivo of the percutaneous absorption of organic solvents.
    Anderson C; Andersson T; Boman A; Molander M
    Curr Probl Dermatol; 1996; 25():37-46. PubMed ID: 8787587
    [No Abstract]   [Full Text] [Related]  

  • 40. Application of topical corticosteroids.
    Mörtenhumer M; Oikarinen A
    Arch Dermatol; 1985 Aug; 121(8):971. PubMed ID: 4026355
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.